MedPath

Effect of supplementation in treatment of women with gestational diabetes

Phase 3
Conditions
Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
E28.2
Registration Number
IRCT201704225623N109
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Pregnant women aged 18-40 years
Diagnosed with GDM at 24-28 weeks' gestation

Exclusion Criteria

History of placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Kidney or liver diseases
Taking magnesium, zinc, calcium and vitamin D supplements prior to intervention
Being smoker
Insulin therapy after GDM diagnosis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: ELISA kit.;Total nitrite. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath